Recombinant DNA technology enables individual fragments of DNA from any genome to be inserted into vector DNA molecules such as plasmids and individually amplified in bacteria. Each amplified fragment is called a DNA clone.
How does recombinant DNA technology work? The organism under study, which will be used to donate DNA for the analysis, is called the donor organism. The basic procedure is to extract and cut up DNA from a donor genome into fragments containing from one to several genes and allow these fragments to insert themselves individually into opened-up small autonomously replicating DNA molecules such as bacterial plasmids. These small circular molecules act as carriers, or vectors, for the DNA fragments. The vector molecules with their inserts are called recombinant DNA because they consist of novel combinations of DNA from the donor genome (which can be from any organism) with vector DNA from a completely different source (generally a bacterial plasmid or a virus). The recombinant DNA mixture is then used to transform bacterial cells, and it is common for single recombinant vector molecules to find their way into individual bacterial cells. Bacterial cells are plated and allowed to grow into colonies. An individual transformed cell with a single recombinant vector will divide into a colony with millions of cells, all carrying the same recombinant vector. Therefore an individual colony contains a very large population of identical DNA inserts, and this population is called a DNA clone. A great deal of the analysis of the cloned DNA fragment can be performed at the stage when it is in the bacterial host. Later, however, it is often desirable to reintroduce the cloned DNA back into cells of the original donor organism to carry out specific manipulations of genome structure and function. Hence the protocol is often as follows:

Cloning allows the amplification and recovery of a specific DNA segment from a large, complex DNA sample such as a genome.
Recombinant DNA technology enables individual fragments of DNA from any genome to be inserted into vector DNA molecules such as plasmids and individually amplified in bacteria. Each amplified fragment is called a DNA clone.
The term recombinant DNA must be distinguished from the natural DNA recombinants that result from crossing-over between homologous chromosomes in both eukaryotes and prokaryotes. Recombinant DNA in the sense being used in this chapter is an unnatural union of DNAs from nonhomologous sources, usually from different organisms. Some geneticists prefer the alternative name chimeric DNA, after the mythological Greek monster Chimera. Down through the ages, the Chimera has stood as the symbol of an impossible biological union, a combination of parts of different animals. Likewise, recombinant DNA is a DNA chimera and would be impossible without the experimental manipulation that we call recombinant DNA technology.
Plasmids such as those carrying genes for resistance to the antibiotic tetracycline (top left) can be separated from the bacterial chromosomal DNA. Because differential binding of ethidium bromide by the two DNA species makes the circular plasmid DNA denser than the chromosomal DNA, the plasmids form a distinct band on centrifugation in a cesium chloride gradient and can be separated (bottom left). They can then be introduced into bacterial cells by transformation (right). (Modified from S. N. Cohen, “The Manipulation of Genes.” Copyright © 1975 by Scientific American, Inc. All rights reserved.)
The breakthrough that made recombinant DNA technology possible was the discovery and characterization of restriction enzymes. Restriction enzymes are produced by bacteria as a defense mechanism against phages. The enzymes act like scissors, cutting up the DNA of the phage and thereby inactivating it. Importantly, restriction enzymes do not cut randomly; rather, they cut at specific DNA target sequences, which is one of the key features that make them suitable for DNA manipulation. Any DNA molecule, from viruses to humans, contains restriction-enzyme target sites purely by chance and therefore may be cut into defined fragments of size suitable for cloning. Restriction sites are not relevant to the function of the organism, nor would they be cut in vivo, because most organisms do not have restriction enzymes.
Let’s look at an example: the restriction enzyme EcoRI (from E. coli) recognizes the following sixnucleotide-pair sequence in the DNA of any organism:

This type of segment is called a DNA palindrome, which means that both strands have the same nucleotide sequence but in antiparallel orientation. Many different restriction enzymes recognize and cut specific palindromes. The enzyme EcoRI cuts within this sequence but in a pair of staggered cuts between the G and the A nucleotides:

The restriction enzyme EcoRI cuts a circular DNA molecule bearing one target sequence, resulting in a linear molecule with single-stranded sticky ends.
Restriction enzymes have two properties useful in recombinant DNA technology. First, they cut DNA into fragments of a size suitable for cloning. Second, many restriction enzymes make staggered cuts generating single-stranded sticky ends conducive to the formation of recombinant DNA.
Dozens of restriction enzymes with different sequence specificities have now been identified, some of which are shown in Table 10-1. You will notice that all the target sequences are palindromes, but, like EcoRI, some enzymes make staggered cuts, whereas others make flush cuts. Even flush cuts, which lack sticky ends, can be used for making recombinant DNA.
DNA can also be cut by mechanical shearing. For example, agitating DNA in a blender will break up the long chromosome-sized molecules into flush-ended clonable segments.
Method for generating a chimeric DNA plasmid containing genes derived from foreign DNA. (From S. N. Cohen, “The Manipulation of Genes.” Copyright © 1975 by Scientific American, Inc. All rights reserved.)
How amplification works. Restriction enzyme treatment of donor DNA and vector allows insertion of single fragments into vectors. A single vector enters a bacterial host, where replication and cell division result in a large number of copies of the donor fragment.